Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study

Publisher： Karger

E-ISSN： 1423-0232|67|3-4|257-261

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.3-4, 2004-11, pp. : 257-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 356-363

Karger

Access to resources Recommend Favorite

A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 330-338

Karger

Access to resources Recommend Favorite

A Phase I Dose-Escalating and Pharmacokinetic Study of Docetaxel and Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 322-325

Karger

Access to resources Recommend Favorite

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

A Phase I Study of UFT-Oral Vinorelbine in Metastatic Breast Cancer

By  

Oncology, Vol. 81, Iss. 2, 2011-09 ,pp. : 73-78

Karger

Access to resources Recommend Favorite